The Middle EAST Genotyping Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several factors, including the increasing prevalence of genetic disorders, advancements in genomic technologies, and the rising demand for personalized medicine. The region is witnessing a surge in...
Deutsch 
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek